C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2006
12/06/2006	CN1288137C 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone
12/05/2006	US7145006 PNA monomer and precursor
12/05/2006	US7144916 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
12/05/2006	US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents
12/05/2006	US7144906 Heterocyclic compounds
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144885 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
12/05/2006	US7144691 Oxiranylmethoxyhydrocarbyl-N-oxypiperidine derivatives as stabilizers; blue sensitive silver halide emulsion layer yellow coupler, green sensitive layer contains magenta coupler, and red sensitive layer contains cyan coupler; storage stability
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
12/05/2006	CA2203078C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]indoles as estrogenic agents
12/03/2006	CA2547744A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
11/2006
11/30/2006	WO2006127396A1 Par2-modulating compounds and their use
11/30/2006	WO2006127379A2 Par2-modulating compounds and their use
11/30/2006	WO2006126939A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006126938A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006126695A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	WO2006126035A2 Process for the preparation of rosuvastatin
11/30/2006	WO2006125972A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
11/30/2006	WO2006125687A1 Heteroaroyl-substituted serine amides
11/30/2006	WO2006125621A1 Substituted piperidines as renin inhibitors
11/30/2006	WO2006125324A1 Treatment of protein folding disorders
11/30/2006	WO2006111858A3 Bis-(coumarin) compounds with anti-inflammatory activity
11/30/2006	WO2006111662A3 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
11/30/2006	US20060270858 A process for preparation of 1-[9h-carbazol-4-yloxy]-3-[{2-(2-(methoxy)phenoxy)-ethyl}-amino]-propan-2-ol
11/30/2006	US20060270713 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/30/2006	US20060270706 Cyclic amine derivative having heteroaryl ring
11/30/2006	US20060270672 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
11/30/2006	US20060270649 Azetidine derivatives, their preparation and medicaments containing them
11/30/2006	US20060270632 4-(2-Furoyl) aminopiperidine compound useful as therapeutic agent for itching
11/30/2006	CA2609980A1 Treatment of protein folding disorders
11/30/2006	CA2609747A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2609735A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2609394A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	CA2609392A1 Modulators of atp-binding cassette transporters
11/30/2006	CA2609243A1 Heteroaroyl-substituted serine amides
11/30/2006	CA2609235A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
11/30/2006	CA2608685A1 Substituted piperidines as renin inhibitors
11/30/2006	CA2607280A1 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
11/29/2006	EP1726592A1 Dioxino derivatives and their use as dopanine agonists
11/29/2006	EP1726591A2 Process for manufacturing paroxetine hydrochloride hemihydrate
11/29/2006	EP1726589A2 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof
11/29/2006	EP1726585A1 Diaryl-substituted five-membered heterocycle derivative
11/29/2006	EP1726584A1 2-aminoquinazoline derivative
11/29/2006	EP1725568A1 Process for preparing cephalosporin intermediates using alpha-iod o-1-azetidineacetic acid esters and trialkylphosphites
11/29/2006	EP1725548A2 Processes and intermediates for the preparation of aspartic acetal caspase inhibitors
11/29/2006	EP1725547A1 Process for preparing n-aryl-piperazine derivatives cross-reference to related applications
11/29/2006	EP1725544A1 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
11/29/2006	EP1725540A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
11/29/2006	EP1725538A1 Pyridazinone ureas as antagonists of a4 integrins
11/29/2006	EP1725535A2 Hiv integrase inhibitors
11/29/2006	EP1725529A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
11/29/2006	EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725103A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
11/29/2006	EP1572207A4 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
11/29/2006	EP1553947A4 Quinazolinones and derivatives thereof as factor xa inhibitors
11/29/2006	EP1114028B1 Aza-bicycles which modulate the inhibition of cell adhesion
11/29/2006	EP1043995B1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
11/29/2006	CN1871237A 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-IV inhibitors
11/29/2006	CN1871233A Novel chelating agents and chelates and their use
11/29/2006	CN1871231A 吡嗪衍生物及其医药用途 Pyrazine derivatives and pharmaceutical use
11/29/2006	CN1871009A 5-arylpyrimidines as anticancer agents
11/29/2006	CN1870991A Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
11/29/2006	CN1870988A 2-azetidinones as anti-hypercholesterolemic agents
11/29/2006	CN1286833C Indole and 2,3-indoline derivative, their preparation and application
11/29/2006	CN1286831C N-ureido-piperidines as antagonists viii for CCR-3 receptor
11/29/2006	CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/29/2006	CN1286817C Process for the preparation of benazepril hydrochloride
11/29/2006	CN1286812C Bispiperidines as antithrombotic agents
11/29/2006	CN1286764C Non-heating clay composites for building materials
11/28/2006	US7141680 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide)
11/28/2006	US7141671 Biphenyl derivatives
11/28/2006	US7141609 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/28/2006	US7141590 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides
11/28/2006	US7141586 Nicotinamide derivatives useful as PDE4 inhibitors
11/28/2006	US7141585 Pyrazole derivatives
11/28/2006	US7141584 2-(substituted-phenyl)amino-imidazoline derivatives
11/28/2006	US7141577 Antitumor agents
11/28/2006	US7141574 Viral polymerase inhibitors
11/28/2006	US7141564 are active against a wide range of organisms including both Gram-negative and Gram-positive organisms
11/28/2006	US7141561 Substituted diaryl heterocycles, process for their preparation and their use as medicaments
11/28/2006	US7141352 Basic compound, resist composition and patterning process
11/28/2006	US7141351 Basic compound, resist composition and patterning process
11/28/2006	CA2268775C Process for the preparation of phtalide
11/28/2006	CA2228044C Dibenzimidazole radioprotectors
11/28/2006	CA2164633C Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
11/28/2006	CA2155018C C7 taxane derivatives and pharmaceutical compositions containing them
11/28/2006	CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006	WO2006124861A2 Benzofuran compounds
11/23/2006	WO2006124447A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	WO2006123786A1 Cyanine coloring matter and optical recording medium
11/23/2006	WO2006123726A1 Pharmaceutical composition
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006123639A1 Pyrimidine derivative
11/23/2006	WO2006123121A1 Histone deacetylase inhibitors
11/23/2006	WO2006122944A1 Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
11/23/2006	WO2006122926A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
11/23/2006	WO2006122661A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	WO2006098918A3 Substituted gamma lactams as therapeutic agents
11/23/2006	WO2006071538A3 Substituted biaryl analogues
11/23/2006	WO2006069155A3 Inhibitors of protein arginine methyl transferases

1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 694